These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 19137011)
1. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Lin L; Amin R; Gallicano GI; Glasgow E; Jogunoori W; Jessup JM; Zasloff M; Marshall JL; Shetty K; Johnson L; Mishra L; He AR Oncogene; 2009 Feb; 28(7):961-72. PubMed ID: 19137011 [TBL] [Abstract][Full Text] [Related]
2. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128 [TBL] [Abstract][Full Text] [Related]
3. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy. Zuo M; Li C; Lin J; Javle M Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212 [TBL] [Abstract][Full Text] [Related]
4. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776 [TBL] [Abstract][Full Text] [Related]
5. NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma. Chen W; Shen X; Xia X; Xu G; Ma T; Bai X; Liang T Liver Int; 2012 Jan; 32(1):70-7. PubMed ID: 22098470 [TBL] [Abstract][Full Text] [Related]
6. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma. Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071 [TBL] [Abstract][Full Text] [Related]
7. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells. Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525 [TBL] [Abstract][Full Text] [Related]
8. Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3. Tai WT; Cheng AL; Shiau CW; Liu CY; Ko CH; Lin MW; Chen PJ; Chen KF Mol Cancer Ther; 2012 Feb; 11(2):452-63. PubMed ID: 22180308 [TBL] [Abstract][Full Text] [Related]
10. Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma. Hagiwara S; Kudo M; Nagai T; Inoue T; Ueshima K; Nishida N; Watanabe T; Sakurai T Br J Cancer; 2012 Jun; 106(12):1997-2003. PubMed ID: 22596232 [TBL] [Abstract][Full Text] [Related]
11. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo. Mohan CD; Bharathkumar H; Bulusu KC; Pandey V; Rangappa S; Fuchs JE; Shanmugam MK; Dai X; Li F; Deivasigamani A; Hui KM; Kumar AP; Lobie PE; Bender A; Basappa ; Sethi G; Rangappa KS J Biol Chem; 2014 Dec; 289(49):34296-307. PubMed ID: 25320076 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214 [TBL] [Abstract][Full Text] [Related]
13. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879 [TBL] [Abstract][Full Text] [Related]
14. Euphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3. Fan L; Zhu H; Tao W; Liu L; Shan X; Zhao M; Sun D Phytomedicine; 2019 Sep; 62():152931. PubMed ID: 31085375 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma. Zhang L; Li H; Ge C; Li M; Zhao FY; Hou HL; Zhu MX; Tian H; Zhang LX; Chen TY; Jiang GP; Xie HY; Cui Y; Yao M; Li JJ Oncotarget; 2014 Nov; 5(21):10621-35. PubMed ID: 25301737 [TBL] [Abstract][Full Text] [Related]
16. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1. Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595 [TBL] [Abstract][Full Text] [Related]
17. NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells. Hu QD; Chen W; Yan TL; Ma T; Chen CL; Liang C; Zhang Q; Xia XF; Liu H; Zhi X; Zheng XX; Bai XL; Yu XZ; Liang TB Cancer Lett; 2012 Dec; 325(2):207-13. PubMed ID: 22781398 [TBL] [Abstract][Full Text] [Related]
18. IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition Mitra A; Yan J; Xia X; Zhou S; Chen J; Mishra L; Li S Hepatology; 2017 Apr; 65(4):1222-1236. PubMed ID: 27863449 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839 [TBL] [Abstract][Full Text] [Related]
20. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Ding W; Mouzaki M; You H; Laird JC; Mato J; Lu SC; Rountree CB Hepatology; 2009 Apr; 49(4):1277-86. PubMed ID: 19115422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]